Prolonging Gastrointestinal-Stromal-Tumor-free life, an optimal suggestion of imatinib intervention ahead of operation

Background: Imatinib has been regarded as the first successful synthetic small molecule targeting at blocking tyrosine kinase. Its high efficacy stabilized disease in above 80% of chronic myeloid leukemia (CML) patients over 10 years survival. Due to the similar canceration of gastrointestinal strom...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lin-Hai, Chen, Zhi-Ning, Li, Chun-Jun, Chen, Jia, Qin, Yu-Zhou, Chen, Jian-Si, Tang, Wei-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218762/
https://www.ncbi.nlm.nih.gov/pubmed/30410587
http://dx.doi.org/10.7150/jca.25263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218762/
https://www.ncbi.nlm.nih.gov/pubmed/30410587
http://dx.doi.org/10.7150/jca.25263

Ejemplares similares